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ABSTRACT 
NOREPINEPHRINE MEDIATES THE EFFECTS 
OF RESTRAINT STRESS ON 
THEILER'S MURINE ENCEPHALOMYELITIS VIRUS. (April 2002) 
Heath Keay McCullough 
Department of Psychology 
Texas A&M University 
Fellows Advisor: Dr. Mary Meagher 
Department of Psychology 
Theiler's Murine Encephalomyelitis Virus (TMEV) is an important model of 
multiple sclerosis (MS) (Lipton, 1975). Theiler's virus induces a biphasic disease that, 
in the chronic phase, causes a remitting relapsing demyelination of the central nervous 
system (CNS) similar to that of MS. Chronic restraint stress in the acute/early phase 
profoundly affects vulnerability to TMEV. When an animal is subjected to a stressor, 
several biological pathways are activated. Previous studies conducted in our lab have 
investigated the role of the hypothalamic pituitary adrenal (HPA) axis and the 
glucocorticoid corticosterone. The sympathetic nervous system (SNS) is also activated 
by stress and initiates the release of the catecholamine norepinephrine (NE) from the 
adrenal medulla. Norepinephrine is believed to have immunosuppressive effects. 
Here, we attempt to determine if NE is mediating the deleterious effects restraint stress 
on TMEV. To examine this issue, seventy-one 24-day old male CBA mice were 
surgically implanted with either a pellet of the G, -adrenergic antagonist nadolol, or a 
pellet containing only vehicle on three days prior to infection. The mice were then 
restrained for 12 hours overnight, and infected intracranially with 5 X10' PFU of the 
BeAn strain of TMEV on day 0 post infection. For the following 4 weeks, restraint was 
administered 5 nights a week for 12 hours per session. The effects of stress on TMEV 
were measured daily using two scales, one to measure the relative sickness of the 
animal and the second to measure the degree of hind limb weakness and paralysis. 
The body weight of the animals was also recorded daily. This study confirms that 
norepinephrine is indeed a mediator of the stress response. Animals receiving the 
placebo had higher mortality, more severe clinical symptoms, and greater hind limb 
weakness and paralysis than animals receiving the norepinephrine antagonist nadolol. 
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1. Introduction 
A compelling body of evidence supports the idea that the central nervous 
system (CNS) and the immune system are able to communicate. This communication 
allows environmental stimuli such as physical and psychosocial stressors to effectively 
modulate the immune system. There are two main conduits through which the brain is 
able to communicate with the immune system: the hypothalamic pituitary adrenal (HPA) 
axis and the sympathetic division of the autonomic nervous system. External stressors 
are processed by the cerebral cortex and activate the paraventricular nucleus of the 
hypothalamus which secretes corticotropin releasing hormone (CRH). CRH travels to 
the adenohypophysis (anterior pituitary) via the hypophyseal portal system where it 
stimulates release of adrenocorticotropic hormone (ACTH) into the blood stream. 
Circulating ACTH targets the zona glomerulosa of the adrenal cortex resulting in the 
release of glucocorticoids, which then directly influence the activity of immune effector 
cells. 
External stress stimuli also activate the sympathetic nervous system (SNS) 
resulting in the release of catecholamines. The SNS originates in the locus ceruleus of 
the brain stem, from these nuclei, preganglionic efferent fibers run down the spinal cord 
and exit the central nervous system (CNS) via the thoracic and lumber spinal nerves. 
The fibers of the SNS are noradrenergic fibers in that they act by releasing the 
catecholamine norepinephrine (NE). The fact that fibers from the SNS innervate all 
primary and secondary lymphoid organs and individual immune cells have 8, - 
adrenoreceptors for NE provides the second pathway for CNS mediation of the immune 
system (Brodde, Engel, Hoyer, Block & Weber, 1981; Fuchs, Campbell & Munson, 
1988; Madden, Sanders, 8 Felton, 1995. Furthermore, it has been shown that the HPA 
axis and the SNS noradrenergic system seem to participate in mutual positive feedback 
loop where activation of one system leads to activation of the other (Chrousos & Gold, 
1992). 
The influence of stress on the immune system is dependant upon the stressor's 
duration. Acute stress stimulates the immune system by increasing proliferation and 
activity of immune cells and then redistributing them to the areas where they are 
needed (Jellinck, Dhabar & McEwen, 1997). In contrast, chronic stress has been found 
to suppress immune function making the organism more vulnerable to infection. For 
over fifty years evidence has suggested that specific glucocorticoids released by the 
HPA axis in response to stress may mediate this effect. The last two decades have 
seen the accumulation of evidence linking the SNS and its end products, 
catecholamines, to immune system modulation (Elenkov, Wilder, Chrousos, & Vizi, 
2000). Recent studies have shown chronic stress increases susceptibility to herpes 
simplex and influenza viruses in mice and that this effect is mediated by both the 
glucocorticoid, corticosterone, and the catecholamine, norepinephrine (Sheridan, 
Dobbs, Jung, Chu, Konstantinos, Padgett, & Glaser, 1998). These studies found that 
restraint stress suppressed immune responses including natural killer (NK) cell activity, 
the production of the cytokine interleukin (IL-1), lymphodenopathy and mononuclear cell 
trafficking. Now that it seems clear that stress can act through specific biological 
pathways to alter the immune response, logical progression would lead one to inquire 
as to how this suppression effects the pathophysiology of various diseases. 
Stress has been implicated as a contributing factor to the onset and progression 
of several autoimmune diseases in humans, including multiple sclerosis (MS). With 
an incidence of approximately 1:2000 in the United States, MS is the most prevelent 
CNS demyelinating disease in the country. The etiology of MS is presently unknown, 
but one of the most convincing hypotheses proposes that viral infection during 
adolescence and early adulthood may be a catalyst. Anecdotal reports suggest that 
major life stressors frequently trigger the development of MS symptoms (Ackerman, 
Martino, Heyman, Moyna, & Rabin, 1998; Ackerman, Maitino, Heyman, Moyna, & 
Rabin, 1996). Recent studies using standardized assessment of stressful life events 
propose that psychological stress precedes both the onset and exacerbation of MS 
symptoms in up to 70-80'/o of cases (Warren et al. , 1982). Psychological stress can be 
used to predict subsequent development of brain lesions in patients with chronic 
remitting, relapsing forms of MS (Mohr, Goodkin, Boudewyn, Huang, Marietta, Cheuk, 8 
Dee, 2000). However, studies investigating the effects of stress on MS are few and 
whether there is any effect at all remains controversial. For example, one study 
examined MS patients in israel during the missile attacks of the 1991 Persian Gulf War 
and found that the number of relapses during the war and for two months after were 
significantly lower than during the preceding two years (Nisipeanu, 8 Korczyn 1992). 
Theiler's virus serves as an important animal model of MS. Theiler's virus 
induces a chronic remitting relapsing demyelination of the central nervous system 
similar to that of some forms of MS (Lipton, 1975; Fujinami 8 Zurbriggen, 1989). 
Because the disease course is so well characterized (Welsh, Blakemore, Tonks, 
Borrow, 8 Nash, 1989 for review), expedimentation with TMEV provides an excellent 
means of investigating the role of corticosterone and norepinephrine in modulating the 
effects of stress on immunity. Theiler's virus is a picornovirus, which in nature causes 
an acute enteric infection and occasionally paralysis. The virus may be asymptomatic 
or fatal depending on the susceptibility of a particular strain of mouse and the virulence 
of the viral strain. The effects of stress on the pathogenesis of Theiler's virus infection 
in CBA mice were explored by Campbell, Meagher, Sieve, Scott, Storts, Welsh, and 
Welsh, 2000. The study revealed that chronic restraint stress suppressed the immune 
system severely exacerbating the symptomtology of TMEV infection in CBA mice. 
Infected/restrained mice had a higher incidence of clinical symptoms and mortality than 
the infected/nonstressed mice. Compared to control mice, restraint stressed animals 
showed a decreased number of circulating lymphocytes, elevated CNS viral titers, and 
decreased inflammatory cell infiltration into the CNS one week after infection. This 
evidence indicates that restraint stress had immunosuppressive effects. 
Our laboratory further investigated the roles of restraint stress and 
corticosterone. We first determined that restraint stress did indeed have a deleterious 
effect on animal subject's resistance to viral infection. In a second experiment, 
exogenous corticosterone was administered to infected animals in the absence of 
restraint stress in order to discern whether cort was the physiological mediating 
component of the deleterious effect of stress on immune function. We found that 
administration of exogenous corticosterone resulted in almost identical effect on animal 
subject's resistance to viral infection. However, this effect was delayed by 
approximately one week compared to the rapid effect of restraint stress (Meagher, 
Welsh, T. 
, 
Sieve, Satterlee, & Welsh, J. , In Preparation). 
The close connection between the HPA axis and the SNS noradrenergic system 
may explain why administration of exogenous cart resulted in a delayed effect (Koob, 
1999; Crousos et al. 1992). The present study seeks to determine if norepinephrine 
plays an essential role in the stress-induced down regulation of the murine immune 
system. This experiment will use the S, -adrenergic antagonist, nadolol, that was shown 
by Sheridan and colleagues (1998) to effectively blockade the immune 8, receptors. 
The objective of this experiment is to determine whether nadolol will reduce the 
deleterious effects of restraint stress on the immune response of male CBA mice to 
infection with TMEV by blocking the effects of norepinephrine. 
2. Methods 
2. 1 EXPERIMENT 1 
2. 1. 1. Subjects 
Subjects were 71 three-week old male CBA mice (Harlan Laboratory). The 
strain was chosen for its intermediate susceptibility to the BeAn strain of Theiler's virus. 
Twenty-three of the subjects were run in the first trial and forty-eight subjects were run 
in a second trial. Mice were assigned to cages by weight, counterbalancing to insure 
even distribution of heavy and light mice. Mice were housed four per cage in the first 
trial and three per cage in the second trial. Other than this small difference in housing, 
identical procedures were used in each trial. The animals were maintained on a 12- 
hour light/dark cycle. Food and water was available ad libitum. To habituate the mice 
to human contact, all mice were handled for a couple of minutes each day for three 
days prior to the behavioral stress procedures. 
2. 1. 2. Acute Clinical and Paralysis Signs. 
Following one week of acclimation to the laboratory and handling, each animal was 
examined daily for the development of clinical signs indicative of acute neurological 
disease. For each mouse, body weight, clinical score, and paralysis score were 
recorded daily. The clinical score was based on a numerical scale ranging from 0. 00 to 
4. 00 that increased by 0. 25 increments. A score of 0. 00 indicates a healthy animal while 
a score of 3. 00 to 3. 75 indicates severe neurological symptoms and a score of 4. 00 
represents death. Scores were determined by assigning point values to clinical signs of 
illness based upon a standardized subjective system. Interrater reliability was 
demonstrated by all investigators scoring the animals (r = 0. 95). Subjects received one 
quarter point for slightly ruffled fur, and partial grooming. They received additional 
quarter points for exhibiting each of these symptoms to a greater degree (i. e. prominently 
ruffled fur and extremely poor grooming). Animals received full points for displaying 
hunched posture of varying degrees. Other factors that were considered were degree of 
lethargy, sunken or crusted eyes, vocalization to touch, and startle to touch. The 
paralysis score was based on a numerical scale ranging from 0. 00 to 5. 00. Scores were 
assigned to each hind leg using a standardized scoring system that considered hind leg 
weakness, paralysis, and abnormality of gait. A score of 0. 00 indicates a normal, strong 
and functional limb while a score of 5. 00 represents a very weak completely paralyzed 
limb. Interrater reliability was demonstrated for the paralysis scale (r = 0. 95). Baseline 
measures of body weight, clinical and paralysis scores were taken daily during the week 
prior to stress and infection. 
2. 1. 3. Surgical Implantation of Drug Pellet 
After five days of acclimatization to their new environment, cages were randomly 
assigned to one of four experimental conditions: nadolol/restraint, vehicle/restraint, 
nadolol/control, and vehicle/control. The animals were anesthesized with a mixture of 
xylazineand ketamine in lactated ringer's solution. One mL of a stock solution 
consisting of 1 mL xylazine (100 mg/mL) and 10 mL of ketamine (100gm/mL) was 
diluted with 4 mL of sterile lactated ringer's to make the anesthesia. Animals received a 
dose of 0. 006 mL per gram of body weight. Anesthesized animals were shaved on the 
back of the neck with an electric clippers and a 0. 5 cm vertical incision was made just 
below the nape of the neck. The appropriate drug or vehicle pellet was then implanted 
under the dermis between the neck and right shoulder. The incision was closed with 
one Michele clip and the animals were placed in heated cages for one hour to recover 
from the anesthesia. Michele clips were removed two days post surgery. 
2. 1. 4. Behavioral Stress Conditions. 
One week after arrival and one day prior to infection, (day -1 post-infection (pi)), 
mice assigned to the restraint stress condition were placed in well-ventilated 60 mL 
plastic tubes for 12 hours (8 p. m. to 8 a. m. ) five nights per week for four consecutive 
weeks. Inside the tube, the mouse could move forward and backward freely, but he 
could not turn around nor did he have access to food or water. Mice in the control 
condition remained undisturbed in their home cages. 
2. 1. 5. infection 
After the first day of restraint, day 0 pi, all of the mice in the stress and control 
conditions were anesthetized with isofluorine and infected intracranially with 5 x 104 
p. f. u. contained in 20 pl of the BeAn strain of Theiler's virus. 
2. 1. 6 Bleeding 
After acclimation to handling, mice were bled (150 pl/bleed) on days -5, 9, and 
18 pi. Blood was collected by nicking the saphenous vein of the leg. One day prior to 
the bleed, the leg to be bled was shaved to facilitate blood collection. During the 
procedure, a topical anesthetic (Emla) was applied to the shaved leg fifteen minutes 
prior to pricking of the saphenous vein to insure that the animals felt no pain. Mice were 
bled one at a time under a fume hood less than 10 seconds following removal from the 
home cage or restraint tube. The order in which the mice were bled was 
counterbalanced between conditions. On nights of restraint prior to a bleed, mice were 
stagger-restrained (placed in restraint tubes nine minutes apart) to account for the time 
it took to bleed each mouse. In this way, each mouse received the same amount of 
restraint before bleeding. After bleeding, mice were placed in holding cages outside the 
animal colony until all mice were bled. Blood samples were taken into heparinized 
tubes, placed on ice, and centrifuged. The serum was stored at -80 C until it will be 
used for future assays. 
2. f. 7. Statistical Analyses. 
Differences in body weights, clinical, and paralysis scores were analyzed using 
an analysis of variance (ANOVA), to examine the behavioral stress by drug interaction. 
Due to the high and rapid onset of mortality in the restraint conditions, and the 
subsequent loss of subjects, all analyses were run on data from days 0 to 3 post 
infection. 
3. Results 
3. 5. Body Weights 
Subjects were weighed daily to 0. 1 gram accuracy to determine if the nadolol 
and behavioral stress affected weight loss. Restraint stress resulted in significant 
weight loss, restraint groups mean weight = 17. 07, control groups mean weight = 20. 04, 
F (1, 54) = 29. 631, g & . 0001. The drug condition by itself did not significantly alter 
weight between groups, F (1, 54) = 3. 534, p & . 05. As Figure 1 below illustrates, there 
was a significant stress by drug interaction, F (1, 54) = 62. 672, g ~ . 05. 
Interestingly, the stress by drug interaction was only seen in the control groups with 
subjects receiving the nadolol pellet weighing more than subjects receiving the placebo 
(Stat p & . 05). The between conditions interaction was not significant in the restraint 
groups. It is possible that the restraint stress overpowered the drug effect. 
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3. 2. Mortality 
Figure 2 depicts survival curves for each of the four conditions. By day three 
post infection, the vehicle/restrained group began to experience severe mortality. At 
day ten pi the vehicle/restrained groups had suffered 67'/0 mortality compared to less 
than 40'/0 for the nadolollrestrained groups. No mice died in the control (no stress) 
conditions. It appears as though nadolol delayed both the onset and extent of mortality 
for the restraint stressed condition. 
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3. 3. Clinical Scores 
Every day, all subjects were examined for symptoms of neurological disease 
(ruffled fur, poor grooming, hunching, lethargy, and sunken eyes). Increasing clinical 
scores represent worsening of these symptoms. A one within, two between Analysis of 
Variance (ANOVA) showed that restraint stress produced more severe clinical 
symptoms, F (1, 59) = 142. 831, 9 & . 0001, and that administration of the drug nadolol 
resulted in less severe symptoms, F (1, 59) = 7. 552, p & . 0079. As Figure 3 
demonstrates, the interaction between stress and drug was also significant, F (1, 59) = 
5. 687, 2 & . 0203. 
Figure 3 
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Animals receiving the i3, -adrenergic antagonist, nadolol, had less severe symptoms of 
neurological disease than animals receiving placebo in both the restraint and control 
conditions. 
3. 4. Paralysis Scores 
Subjects were scored daily for hind limb weakness and paralysis. An ANOVA 
confirmed that restraint stress produced more severe clinical symptoms, F (1, 58) = 
47. 342, g & . 0001. Administration of the drug nadolol by itself did not yield a significant 
decrease in symptom severity, F (1, 58) = 3. 538, g & . 05, however, as shown in Figure 4 
below, there was a significant stress by drug interaction confirming that nadolol 
administration did reduce the effects of restraint stress on symptoms of neurological 
disease compared to placebo, F (1, 58) = 5. 925, g & . 0180. 
Figure 4 
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4. Conclusions 
The results of this investigation show that the effects of restraint stress on the 
pathogenesis of TMEV in male CBA mice are at least partly mediated by the 
sympathetic nervous system. It was shown that nadolol was successful in reducing the 
deleterious effects of stress on TMEV infection by decreasing weight loss, reducing 
both clinical and paralysis symptomtology of neurological disease, and decreasing 
mortality in restrained mice. There are several possible explanations as to why 
blockage of D, -adrenergic receptors might decrease stress-induced down regulation of 
the immune system. 
In acute TMEV infection, natural killer (NK) cells and cytotoxic T (CD8+) cells 
play a crucial role in the immune response (Welsh et al. , 1989). With the exception of T 
helper 2 (T») cells, all immune cells present E, -adrenergic receptors to varying 
degrees. Recent evidence suggests that NK and T cells bear the greatest number of 
S, -receptors (Van Tits, Michel, Grosse-Wilde, Happel, Eigler, Soliman, & Brodde, 
(1990); Maisel, Harris, Rearden, & Michel, (1990). It has also been shown that 
occupation of S, -receptors by an agonist such as NE elevates intracellular levels of 
cyclic adenosine monophosphate (cAMP) which is associated with reduced NK and T 
cell response (Katz, Zaytoun, 8 Fauci, (1982). Thus, it appears that through modulation 
of cAMP levels, NE may functionally mediate immune activity. Studies by Hellstrand, 
Hermodsson, 8 Stannegard, (1985) serve to further strengthen the role of NE in 
immune suppression. Hellstrand et al. found that addition of catecholamines to immune 
cells in vitro decreased NK cell lytic activity. Catecholamines also inhibit both the the 
phagocytotic ability and the ability to undergo respiratory burst of neutrophils (Zurier, 
Weissmann, Hoffstein, Kammerman, & Tai 1974). 
In addition to the effects that NE appears to have on individual immune cells, it 
also appears to have a generalized effect on cellular immune trafficking. Cytokines are 
hormonelike glycoproteins secreted by some immune cells. Cytokines serve as 
chemical mediators, or immunotransmitters, that serve to regulate the immune 
response. T helper 1 (T„) cells secrete several pro-imflammotory, or type 1, cytokines 
including tumor necrosis factor 8 (TNF-6), interleukin 2 (IL-2), and interferon y (INF-y) 
while T» cells secrete the anti-inflammatory, or type 2, cytokines IL-4, IL-10, and IL- 
13(Abbas, Murphy & Sher, 1996). Importantly, type 1 and type 2 cytokines are mutually 
inhibitory. Not only do type 2 cytokines inhibit macrophage activation, and T cell 
proliferation, but they also inhibit the production of pro-inflammatory type 1 cytokines 
(Abbas et al. , 1996; Fearon & Locksley, 1996; Mosmann 8 Sad, 1996). Even more 
importantly, NE appears to potently inhibit T„activity including type 1 cytokines while 
simultaneously enhancing T» and type 2 cytokine activity (Elenkov, Papanicolaou, 
Wilder, R Chrousos, 1996; Panina-Bordignon, Mazzeo, Lucia, D'Ambrosio, Land, 
Fabbri, Self 8 Sinigaglia, 1997). Norepinephrine alters immune response by regulating 
levels of pro and anti-inflammatory cytokines. The evidence seems strong that NE has 
a potent immuno-suppressive effect on proliferation and trafficking of immune cells. 
This study supports previous findings that chronic restraint stress increases 
susceptibility to the acute phase of Theiler's virus (Campbell et al. , 2000, Meagher et 
al. , In Preparation). In our previous study, we found that administration of exogenous 
corticosterone mimicked the effects of restraint stress on TMEV infection with a one- 
week delay. In the present study, significantly high mortality was seen by day 3 post 
infection. This would seem to support our hypothesis that both the HPA axis and the 
SNS adrenergic system are instrumental in mediating the effects of restraint stress on 
the immune response. Corticosterone by itself produced effects more slowly than 
restraint stress while NE appears to have a more rapid onset. The next step is to 
investigate whether administration of exogenous NE, or another S-adrenergic agonist in 
the absence of restraint stress yields results similar to the present study. If that 
investigation is successful, it would be most interesting to see if administration of both 
cort and NE could exactly replicate the effects of restraint stress on immunity. 
Experimentation using animal models of MS reveals that the neuroendocrine 
mechanisms, by which stress may affect the development of the disease, are complex. 
Theiler's virus provides an illustrative model with which these mechanisms may be 
experimentally manipulated. Theiler's virus will continue to serve as an important model 
of MS due to the current hypothesis that a viral infection early in life may initiate a 
secondary autoimmune response targeting myelin in the CNS. If this hypothesis proves 
to be correct, TMEV will prove to be an even more crucial 
model as it promotes investigation of the acute phase of infection, which may operate 
similarly to the initial viral pathogen involved in multiple sclerosis. 
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